Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of therapeutic effect of olive leaf on cutaneous leishmaniasis in humans
IRCT20240918063090N1Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of olive leaf extract in cutaneous leishmaniasis (CL), sponsored by Lorestan University of Medical Sciences. Started Sep 2024; status: completed.
02
Drugs
olive leaf extract
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT20240918063090N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240918063090N1.